About psoriatic arthritis1
Psoriatic arthritis is a systemic imunomediated disorder characterized by inflammation of joints, surrounding ligaments and tendons, and psoriatic skin lesions.1
Psoriatic arthritis has a significant negative impact on patient functionality, psychology, and quality of life. In one study, psoriatic arthritis was significantly associated with reduced work productivity.2-5
Many patients are diagnosed with psoriatic arthritis approximately 10 years after initial skin symptoms develop.6
Where can I find more information and support?
On November 21, 2019, Amgen acquired from Celgene Corporation the worldwide rights to Otezla® (apremilast).